Cen-Poot NP, Vargas-Echeverría SL, Aguilar-Medina M

Language: Spanish
References: 18
Page: 53-57
PDF size: 775.68 Kb.

ABSTRACT

Introduction: childhood obesity is a public health problem associated with metabolic disorders, including dyslipidemia, which increases cardiovascular risk from a young age. Objective: to describe the lipid profile characteristics of children and adolescents with obesity treated at a secondary care medical unit. Material and methods: a retrospective study was conducted, reviewing 95 medical records of outpatients aged 6 to 17 years with obesity (BMI ≥ p 95) treated between 2023 and 2024 at the pediatric endocrinology service. Weight, height and serum levels of total cholesterol, low-density lipoproteins (LDL), high-density lipoproteins (HDL), and triglycerides were recorded. Statistical analysis was descriptive. Results: males predominated (56.8%). The median age was 12 years. The median total cholesterol was 209 mg/dL, LDL 150 mg/dL, HDL 33 mg/dL, and triglycerides 219 mg/dL. All participants had hypertriglyceridemia, 61.1% with hypercholesterolemia, 77.9% with high LDL, and 75.8% with low HDL. The most frequent combined pattern of lipid abnormality (38.9%) was high total cholesterol, high LDL, low HDL, and high triglycerides. Conclusions: children and adolescents with obesity have a high frequency of dyslipidemia. These findings reinforce the importance of screening and comprehensive management of pediatric patients with obesity.

REFERENCES

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024; 403(10431): 1027-1050. doi: 10.1016/S0140-6736(23)02750-2.

2. Shamah-Levy T, Gaona-Pineda EB, Cuevas-Nasu L, Morales-Ruan C, Valenzuela-Bravo DG, Méndez-Gómez Humaran I et al. Prevalencias de sobrepeso y obesidad en población escolar y adolescente de México. Ensanut Continua 2020-2022. Salud Publica Mex. 2023; 65: s218-s224. doi: 10.21149/14762.

3. Mosca S, Araújo G, Costa V, Correia J, Bandeira A, Martins E et al. Dyslipidemia diagnosis and treatment: risk stratification in children and adolescents. J Nutr Metab. 2022; 2022: 4782344. doi: 10.1155/2022/4782344.

4. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128(Suppl 5): S213-S256. doi: 10.1542/peds.2009-2107C.

5. Candelino M, Tagi VM, Chiarelli F. Cardiovascular risk in children: a burden for future generations. Ital J Pediatr. 2022; 48(1): 57. doi: 10.1186/s13052-022-01250-5.

6. Margolis KL, Greenspan LC, Trower NK, Daley MF, Daniels SR, Lo JC et al. Lipid screening in children and adolescents in community practice: 2007 to 2010. Circ Cardiovasc Qual Outcomes. 2014; 7(5): 718-726. doi: 10.1161/CIRCOUTCOMES.114.000842.

7. Costa-Urrutia P, Colistro V, Franco-Trecu V, Granados J, Álvarez Fariña R, Rodríguez-Arellano ME. Dyslipidemia, obesity, and ethnicity in mexican children. Int J Environ Res Public Health. 2021; 18(23): 12659. doi: 10.3390/ijerph182312659.

8. Bibiloni MD, Salas R, De la Garza YE, Villarreal JZ, Sureda A, Tur JA. Serum lipid profile, prevalence of dyslipidaemia, and associated risk factors among northern mexican adolescents. J Pediatr Gastroenterol Nutr. 2016; 63(5): 544-549. doi: 10.1097/MPG.0000000000001325.

9. Dórame-López NA, Bobadilla-Tapia LE, Tapia-Villaseñor A, Gallegos-Aguilar AC, Serna-Gutiérrez A, Alemán-Mateo H et al. Diagnóstico del estado nutricional, dislipidemia y factores de riesgo asociados en escolares indígenas yaquis. Gac Med Mex. 2024; 160(1): 57-66. doi: 10.24875/GMM.23000358.

10. Singleton CMH, Brar S, Robertson N, DiTommaso L, Fuchs GJ 3rd, Schadler A et al. Cardiometabolic risk factors in South American children: a systematic review and meta-analysis. PLoS One. 2023; 18(11): e0293865. doi: 10.1371/journal.pone.0293865.

11. Arjona-Villicaña RD, Herrera-Sánchez LF, Sumárraga-Ugalde CM, Alcocer-Gamboa MA. Asociación entre el índice de masa corporal y el perfil de lípidos en niños y adolescentes mexicanos con obesidad: un análisis retrospectivo. Bol Med Hosp Infant Mex. 2014; 71(2): 88-94.

12. Nakhleh A, Sakhnini R, Furman E, Shehadeh N. Cardiometabolic risk factors among children and adolescents with overweight and class 1 obesity: a cross-sectional study. Insights from stratification of class 1 obesity. Front Endocrinol (Lausanne). 2023; 14: 1108618. doi: 10.3389/fendo.2023.1108618.

13. Zeljkovic A, Vekic J, Stefanovic A. Obesity and dyslipidemia in early life: impact on cardiometabolic risk. Metabolism. 2024; 156: 155919. doi: 10.1016/j.metabol.2024.155919.

14. Padilla-Rojas MM, Vilchis-Gil J, Zurita-Cruz J, Osorio-Alamillo Y, Huerta-Albarran R, Saltigeral-Simental P, et al. Evaluación nutricional: diagnóstico de sobrepeso/obesidad y sus comorbilidades. Rev Mex Pediatr. 2023; 90(Suppl 1): s10-s17. doi: 10.35366/115875.

15. Lim CYS, Foo YW, Tok CLX, Lim YY, Loke KY, Lee YS et al. Screening for metabolic complications of childhood and adolescent obesity: a scoping review of national and international guidelines. Obes Rev. 2022; 23(12): e13513. doi: 10.1111/obr.13513.

16. Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023; 151(2): e2022060640. doi: 10.1542/peds.2022-060640.

17. Villasís-Keever MÁ, Zurita-Cruz J. El papel de los pediatras en el manejo de niños y adolescentes con sobrepeso u obesidad. Rev Mex Pediatr. 2023; 90(Suppl 1): s4-s9. doi: 10.35366/115874.

18. Valerio G, Di Bonito P, Calcaterra V, Cherubini V, Corica D, De Sanctis L et al. Cardiometabolic risk in children and adolescents with obesity: a position paper of the Italian Society for Pediatric Endocrinology and Diabetology. Ital J Pediatr. 2024; 50: 205. doi: 10.1186/s13052-024-01767-x.